It’s long past time for the industry to fully embrace the digital age. It’s fine to keep paper back-ups of data, but using ...

From Big Pharma to biotech—and a globe-spanning journey along the way—Yvonne Greenstreet, this year’s Healthcare ...

As of the writing of this column (May 1), the XBI stood at $88.30, well off of its recent recovery high of $102+ on Feb. 27, ...

The National Institute for Public Employee Healthcare Policy attributed the importance to the rising cost of health care.

Respondents said they were concerned about their own mental health or the mental health of another person at higher rates ...

For decades, one of the main priorities of the United States healthcare system has been to develop life-saving treatments for ...

The FDA first approved Ozempic, Novo Nordisk’s GLP-1 receptor agonist to improve glycemic control in adults with type 2 ...

The new care center will offer primary care services to uninsured and underinsured patients in the Wilmington, North Carolina ...

Strategic financing from Oaktree Capital Management and OMERS Life Sciences is expected to support the US launch of ...

In this Pharmaceutical Executive video interview, Panna Sharma, CEO, Lantern Pharma, talks about ensuring global access to LP ...

Cencora’s vice president of product management, global products & solutions Beth Riggio discusses the issues the industry ...

Myhibbin is reportedly the first FDA-approved liquid formulation of mycophenolate, a key immunosuppressant used to prevent ...